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The development of renal  disease  in  patients  with systemic  lupus  erythematosus 
(SLE)  1 and in NZB ×  NZW F1 hybrid mice is associated with a high titer of anti-DNA 
antibodies in serum (1-3). However, the presence of anti-DNA antibodies is not necessar- 
ily associated with tissue injury (4, 5). There is evidence that anti-DNA antibodies are 
involved in the pathogenesis of SLE through the formation of immune complexes with 
DNA released in circulating blood or in extravascular spaces (2, 3, 6, 7). 
The origin of  DNA participating in the formation of immune complexes in SLE and the 
mechanisms by which such DNA-anti-DNA complexes are localized in tissues are still 
unclear. Although circulating immune complexes have been detected by various methods 
in patients with SLE (8--12), only small amounts of  circulating DNA-anti-DNA complexes 
have been found  (10,  13). Particular mechanisms may be involved in their selective 
concentration in tissues as suggested by the demonstration of a high affinity of DNA for 
collagen or glomerular basement membrane (GBM) (14). 
In  view  of the  biological  changes  occurring  in  mice  after  the  injection  of 
bacterial lipopolysaccharides (LPS),  this experimental model may be suitable 
for the investigation of these particular features of SLE. It is well known that in 
vivo LPS can cause various tissue lesions which are probably not related to 
immunopathological mechanisms (15-17). However, it has been observed that 
DNA appears in circulating blood soon after the injection of LPS and there is a 
subsequent formation of anti-DNA antibodies (18). In the present study, the 
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possible interactions between released DNA and corresponding antibodies have 
been  studied.  Firstly,  DNA  occurring  in circulating blood was purified  and 
characterized;  secondly,  the possible formation and localization of DNA-anti- 
DNA complexes were investigated; and thirdly, the kinetics of serological and 
tissue changes have been followed in order to better define the possible mecha- 
nisms involved in the tissue deposition of DNA-anti-DNA complexes. 
Materials and Methods 
Mice.  6- to 10-wk-old mice were used throughout the study.  C57BL/6,  BALB/c, and DBA/2 
female mice were purchased from Charles River Breeding Laboratories, Inc., Elbeuf, France. OF1 
outbred female mice were purchased from IFFA CREDO (Centre de Recherche et d'Elevage des 
Oncins, St. Germain-sur-I'Arbresle, France). Blood samples were collected by orbital sinus punc- 
ture and the sera were stored at -20°C until used. 
LPS.  Polysaccharides B  of Salmonella typhimurium  (lot 563628), S. enteriditis  (lot 586088), 
Escherichia coli 0127:B8  (lot 582337),  and E. coli  0111:B4  (lot 587667) were obtained from Difco 
Laboratories, Detroit, Mich. Lipid A extracted from E. coli 0111:B4 were kindly provided by Dr. D. 
Morrison  (Scripps  Clinic and  Research Foundation,  La Jolla,  Calif.).  Alkali-treated LPS was 
prepared as follows: 1 ml ofS. typhimurium LPS solution in distilled water was incubated with 0.5 
ml of 0.25 N  NaOH for 1 h  at 37°C  (19). After incubation,  0.5 ml of 0.25  N  HC1  was added to 
neutralize the sample and then dialyzed against saline. All the LPS preparations were diluted to 
the desired concentration in saline and were injected intraperitoneally in a final vol of 0.2 ml. 
DNA.  Highly polymerized calf thymus DNA (type V) was purchased from Sigma Chemical 
Co.,  St.  Louis,  Mo.  Bacterial  DNA from Micrococcus  lysodeikticus was  purified by  Marmur's 
technique (20).  Denatured DNA was prepared by heating native DNA [0.5 mg/ml in phosphate- 
buffered saline (PBS), 0.01  M, pH 7.0] at 100°C for 10 min and by transferring directly to an ice 
bath.  Immunization of mice with DNA for preparation  of anti-single-stranded  DNA (SSDNA) 
antisera was carried out as described previously (18). 
Radiolabeling Procedures.  Calf thymus DNA was labeled with iodine (1~5I) according to the 
method of Commerford (21). This DNA preparation was shown to contain less than 1% of pronase- 
sensitive material.  The radiolabeled DNA was fractionated on methylated  albumin kieselguhr 
columns in order to obtain pure SSDNA (22). Pure  125I-labeled double-stranded  DNA (DSDNA) 
was  prepared  by  treating  ~SI-labeled  native  DNA  with  single-strand  specific  S1  nuclease 
(Seikagaku  Kogyo, Tokyo, Japan)  (23).  For labeling of LPS,  LPS was further  purified by the 
phenol-water extraction method, followed by fractionation with ethanol and ultracentrifugation 
(24). The labeling of LPS with 51Cr was carried out according to the method of Braude et al. (25). 
This  [51Cr]LPS  preparation  was shown  to contain  less than  1%  of pronase-sensitive  material. 
Bovine serum albumin (Calbiochem, San Diego, Calif.) and human  IgG were labeled with ~25I 
according to the procedure  of McConahey and  Dixon (26).  Clq was purified from fresh human 
serum by the method of Yonemasu and Stroud (27) and was labeled with ~=I according to Heusser 
et al.  (28). 
Purification and Charaeterization of  DNA in Circulating Blood.  The amount of DNA released 
into circulating blood after injection of LPS was determined by inhibition of radioimmunoassay as 
described previously (18).  To avoid the contamination  of nuclear DNA from leukocytes,  blood 
samples were carefully collected into EDTA or heparinized tubes. Circulating DNA was purified 
by  affinity column chromatography  and  CsC1  density  gradient  centrifugation.  2  ml of pooled 
plasma collected 12 h after a single injection ofl00/zgS, typhimurium LPS was applied to a CNBr- 
activated Sepharose 4B (Pharmacia Fine Chemicals AB, Uppsala, Sweden) column coated with 
anti-DNA antibodies which reacted with beth SSDNA and DSDNA. Bound DNA was eluted by 2.5 
M KSCN (pH 6.0)  and dialyzed against 0.15  M NaC1 containing 3 mM EDTA. This crude DNA 
fraction was treated with pronase (1 mg/ml: 45,000 proteolytic units/g; Calbiochem) at 37°C over- 
night and mixed with CsC1  (Merck,  A.,  G., Inc., Darmstadt,  W.  Germany)  in 0.02  M Tris-HCl 
buffer (pH 8.5).  The density was adjusted to 1.700 g/cm  3 with either solid CsC1 or Tris-HC1 buffer. 
This solution was centrifuged at 36,000 rpm at 18°C for 60 h with a SW65-Ti rotor in a Spineo L2- 
65B preparative ultracentrifuge (Beckman Instruments, Inc., Palo Alto, Calif.). DNA in fractions 
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and some of this purified DNA was labeled with lzsI. This labeled DNA contained less than 5% of 
pronase-sensitive material and had asp act of about 5  x  104 cpm/~g. 
To determine the density of the released DNA,  125I-labeled purified DNA in CsC1 was centri- 
fuged at 36,000 rpm at 18°C for 60 h. Four-drop fractions were collected. Some fractions were used 
to measure refractive index, the remaining fractions being used to determine radioactivity in an 
automatic Beckman gamma counter. The molecular size of DNA was determined by using sucrose 
density gradients.  0.5 ml of plasma diluted 1/lO in borate buffer (ionic strength 0.1,  pH 8.4) or 
purified DNA was layered on 4.5 ml of 10-40% (wt/vol) linear sucrose gradient in borate buffer 
containing 3 mM EDTA. The samples were centrifuged at 40,000 rpm at 4°C for 18 h with a SW65-Ti 
rotor.  Serial fractions were  collected and optical  density patterns were  recorded by a  Uvicord 
(LKB-Produkter,  Bromnm,  Sweden).  The  19 S  peak  of plasma  was used one reference  marker. 
[l~sI]IgG or [~SI]BSA was centrifuged in control tubes and used as a 7 S or 4.5 S reference marker. 
The apparent S  values were calculated according to the method of Martin and Ames (29).  The 
gradients were divided into nine fractions which were dialyzed against borate buffer before the 
examination of DNA content by the radioimmunoassay. To control the specificity, 0.1 ml of each 
fraction was treated with 0.05 ml of 1 mg/ml DNase (deoxyribonuclease I, 2,600 U/rag; Worthington 
Biochemical Corp., Freehold, N. J.) in Veronal-buffered saline containing Mg  ÷÷ (VBS), pH 7.2, for 
3 h  at 37°C.  Then, 0.025 ml of 0.03 M EDTA (pH 7.0) was added. As undigested control, the same 
fractions were incubated with DNase in the presence of EDTA. 
Radioimmunological Detection of Anti-DNA and Anti-LPS Antibodies.  The titration of anti- 
DNA antibodies was carried out using a  modification of the Farr DNA-binding radioimmunoas- 
say. 0.1 ml of sera diluted 1/lo in borate buffer was heated at 56°C for 30 min, then mixed with 10 ng 
of ~25I-labeled  calf thymus SSDNA in the presence of sodium dodecyl sulfate (SDS; final concentra- 
tion, 0.025%) in order to eliminate the nonspecific binding of DNA by nonimmunoglobulin basic 
proteins. The details were described previously (30).  Titration of anti-DNA antibodies was also 
carried out on sera fractionated by gel filtration on Sephadex G-200 column (18). 
For the titration of anti-LPS antibodies, a radioimmunological method was developed. Briefly, 
0.1 ml of sera diluted 1/1o in borate buffer was heated at 56°C for 30 min, then mixed with 0.1 ttg of 
5~Cr-labeled LPS in 0.2 ml of borate buffer in the presence of 0.1 ml of 0.1% SDS (final concentra- 
tion, 0.025%).  The mixture was incubated for 2 h  at 37°C,  then 1.2 ml of 20% polyethylene glycol 
(PEG, average tool wt 6,000; Siegfried, Zofingen, Switzerland) in borate buffer was added to yield 
a  final concentration of 15%.  After an overnight incubation at 40C, the tubes were centrifuged at 
1,000g for 30 min, then washed with 3 ml of 15% PEG. The results were expressed as a percentage 
of [5~Cr]LPS precipitated.  In this method,  free labeled LPS is soluble in 15%  PEG,  while LPS 
bound  to  antibodies  is  precipitated.  Analysis  of numerous  immune  sera  indicated  that  the 
sensitivity and specificity of this new method was comparable to that of the passive hemagglutina- 
tion test for detection of 19 S anti-LPS antibodies but better for the detection of corresponding 7 S 
antibodies. 
Detection  of Circulating Immune  Complexes.  The  presence  of circulating  DNA-anti-DNA 
complexes  was  examined  according to  the  method  of Herbeck  et  al.  (9).  Using the  antigen- 
nonspecific method, the presence of immune complex-like material in circulation was examined by 
a  modified [~25I]Clq-binding test (11).  The effect of DNase treatment or reduction by 2-mercapto- 
ethanol (2-ME) on the serum [~25I]C1q-binding activity was carried out according to Zubler et al. 
(31). 
Determination of C3 Level in Sera.  Blood C3 level was determined by radial immunodiffusion 
in agar by the method of Mancini et al. (32) and was expressed as a percentage of the normal pool 
values. Sera were assayed immediately after collection. 
Studies of  Kidney Tissues.  Samples of renal tissue from mice injected with LPS were studied 
for routine histology with hematoxylin-eosin, trichrome Masson, and periodic acid-Schiff stains, 
and  by  immunofluoreecence.  For  immunofluorescence,  kidney  specimens  were  snap-frozen  in 
liquid nitrogen and sections of 4-/xm thickness were used.  Goat anti-mouse 7 S IgG antisera and 
monospecific anti-mouse IgM antisera were purchased from Meloy Laboratories Inc., Springfield, 
Va.  Rabbit anti-rat C3 antisera,  which cress-react with mouse C3,  were obtained from Nordic 
Immunology  Laboratories,  Tilburg,  The Netherlands.  The  above antisera  were  conjugated  to 
fluorescein isothiocyanate (Baltimore Biological Laboratories,  Cockeysville,  Md.) following the 
method  of Clark  and  Shepard  (33).  To  elute  immunoglobulins from  kidney  sections,  unfixed 
cryostat sections were treated with 0.12 M glycine-HC1 buffer (pH 3.0) for 1 h  at 37°C,  or with 2.5 1118  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
M KSCN (pH 6.0) for 30 min at room temperature. After elutipn, these sections were washed for 30 
rain in PBS (pH 7.2) and then incubated with the appropriate fluorescent  reagents. For electron 
microscope studies,  kidneys were fixed in phosphate-buffered  2% glutaraldehyde, post-fixed in 
osmic acid, dehydrated, embedded in Epon, sectioned, and stained with uranyl acetate and lead 
citrate. 
Elution of  Kidney-Fixedlmmunoglobulins.  Kidney-fixed immunoglobulins  were eluted by the 
method of Lambert and Dixon (3) with a modification.  For elution, saline-inseluble sediments of 
kidney homogenate were treated with equal volume of DNase (1 mg/ml in VBS) for 1 h at 37°C and 
overnight at 4°C, followed by elution with 2.5 M KSCN (pH 6.0) at room temperature for 1 h. 
Eluates obtained were dialyzed against 0.15 M NaC1. The immunoglobulins  in the eluates were 
isolated  by precipitation in ammonium sulfate at 50% saturation at pH 7.0. The eluates were 
studied  by immunoelectrophoresis  analysis. The amount of IgG and IgM in the eluates was 
estimated by a radial immunodiffusion in agar and was expressed in micrograms of immunoglobu- 
lins per gram of kidneys.  For standard immunoglobulins,  mouse IgG and IgM myeloma proteins 
were purchased from Litton Bionetics,  Kensington,  Md. The amount of anti-DNA antibodies  in 
the eluates was determined by quantitative absorption at 4°C with CNBr-activated Sepharose 4B 
coated with both SSDNA and DSDNA. The immunoglobulin concentration was determined by 
quantitative radial immunodiffusion before and after absorption.  As control, equivalent amounts 
of purified  mouse  myeloma IgG and IgM were subjected  to absorption experiment. Antibody 
activities against SSDNA and LPS in the eluates were determined by radioimmunoassays. For 
titration, different amounts of heat-inactivated eluates were incubated with radiolabeled  antigens 
in the presence of 0.1 ml of 10% heat-inactivated normal mouse serum (NMS) containing 3 mM 
EDTA. As control,  equivalent amounts of purified mouse myeloma immunoglobulins were incu- 
bated with radiolabeled  antigens in the presence of NMS. 
Results 
Purification and Characterization of Circulating DNA in Mice Injected with 
LPS.  A relatively large amount of DNA, 0.3-2 ~g/ml of plasma (mean -+ 1 SD; 
0.83  _+  0.68  /xg/ml),  has been detected  in circulating blood  12 h  after a  single 
injection of 100 ~g S, typhimurium  LPS into  10 C57BL/6 mice, while no DNA 
could be detected in plasma of control C57BL/6 mice. Such plasma samples have 
been pooled and used for the purification of DNA. The purification was achieved 
by affinity column chromatography and CsC1 density gradient ultracentrifuga- 
tion,  and the DNA obtained was then further characterized. 
In order to determine the size of this DNA, the purified fraction was subjected 
to sedimentation velocity analysis in a sucrose density gradient (10-40% wt/vol). 
After ultracentrifugation,  the presence of DNA was determined in each fraction 
by radioimmunoassay. The specificity was controlled by treatment with DNase. 
DNA was demonstrated in gradient fractions containing 4-6 S  material.  When 
'z~I-labeled purified  DNA  was  examined,  the  peak  of radioactivity  was  also 
found in tubes containing 4-6 S material. The same methodology was applied to 
a  plasma pool from mice injected with LPS, and DNA was again demonstrated 
in gradient fractions containing 4-6 S  material. 
The released DNA has been characterized by CsC1 buoyant density gradient 
analysis for comparison with mammalian  cellular DNA.  For this purpose, the 
'2~I-labeled DNA purified from the plasma pool of mice injected with LPS was 
subjected  to  CsC1  density  gradient  analysis.  This  released  DNA banded  in  a 
broader peak than that obtained in separate control experiments with marker 
M. lysodeikticus (p = 1.731 g/cm  a) and calf thymus (p  =  1.700 g/cm  3) DNA. The 
peak  of radioactivity  was  found  at  a  density  of approximately  1.700  g/cm  3, 
indicating its general similarity to double-stranded mammalian  cellular DNA. IZUI,  LAMBERT,  FOURNIE,  TURLER,  AND  MIESCHER 
TABLE  I 
Immunochemical Property of DNA Released after Injection  of LPS 
1119 
Added DNA  [~25I]SSDNA ppt* ['2~I]DSDNA ppt* 
%  % 
NMS$  49§  2 
NMS  + purified  DNA~I  45  NT~ 
NMS  + heat-denatured  purified  DNA  34  NT 
* 0.1 ml of mouse anti-SSDNA antiserum (1:300)  diluted in borate buffer was added to 0.1 
ml of tested DNA sample in 10% NMS, then to 10 ng of [I~I]SSDNA or [I~I]DSDNA in a 
direct binding test. 
Pool of serum from 8-wk-old normal C57BL/6 mice. 
§ Mean of duplicate. 
II DNA purified from a plasma pool of C57BL/6 mice injected with S. typhimurium LPS. 
¶ NT, not tested. 
To exclude the possibility that DNA contaminating the LPS preparations 
could appear in the circulating blood after injection of LPS, the amount of DNA 
present in the preparations of LPS was determined by inhibition of radioimmu- 
noassay. No DNA could be detected in the preparations ofS. typhimurium LPS 
which had been used. 
The purified DNA was further characterized by immunochemical analysis. 
The purified DNA slightly inhibited the reactivity of mouse anti-SSDNA anti- 
bodies with [12sI]SSDNA but this inhibition was considerably increased after 
heat denaturation of that DNA (Table I). The purified DNA also inhibited the 
reactivity of human anti-(DS+SS)DNA antibodies with  [125I]DSDNA. There- 
fore, DNA purified from plasma of mice injected with LPS may react immuno- 
chemically as a mixture of SSDNA and DSDNA or DSDNA with some single- 
stranded regions. 
Anti-DNA, Anti-LPS Antibodies,  and Circulating Immune Complexes after 
Injection ofLPS.  Anti-DNA and anti-LPS responses were followed in C57BL/6 
mice after a single intraperitoneal injection with 100/zg ofS. typhimurium LPS. 
The titers of serum anti-DNA antibodies and anti-LPS antibodies, expressed in 
percentage of [125I]SSDNA and [sJCr]LPS precipitated, were measured on days 1, 
2, 3, 8,  15, and 30. A shown in Fig. 1, on the 3rd day after a single injection of 
LPS,  a  significant anti-DNA response was induced. The peak response was 
observed on day 8  and serum DNA-binding activity decreased slowly after- 
wards. On the other hand, anti-LPS antibodies developed more slowly than anti- 
DNA antibodies. A high level of anti-LPS antibodies remained until day 30. 
Mice receiving saline did not show any significant binding activity to DNA or to 
LPS during that period. Anti-DNA antibodies induced by a  single injection of 
LPS were shown by Sephadex G-200 gel filtration analysis to belong to both the 
IgM and IgG classes. 
The reactivity of anti-DNA antibodies induced by LPS to the DNA released 
after the injection of LPS was investigated. Sera from mice injected with LPS 
showed a  significant binding activity to  [~25I]DNA purified from circulating 
blood of  LPS-injected mice (% binding _+ 1 SD: sera on day 8, 15.0 _+ 0.9%; control 
sera, 8.5 -  1.3%). 
In view of the association of (a) the release of DNA and (b) the appearance of 1120  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
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FIG.  1.  Induction  of anti-DNA  antibodies  in  C57BL/6  mice  after  a  single  injection  of 
bacterial LPS. 100 ~g ofS. typhimurium  LPS was injected intraperitoneally on day 0. Anti- 
DNA  level  is  expressed  as  the  mean  percentage  (7-10  mice  in  each  examination)  of 
[125I]SSDNA precipitated  (O--O).  Anti-LPS level is expressed as the mean percentage of 
[51Cr]LPS precipitated  (0---0).  Vertical bars represent the limits of 1 SD. 
TABLE  II 
Effect of DNase Treatment on Serum DNA-Binding Activity 
Sera  Treatment 
[lzsIISSDNA ppt* 
Day 2  Day 3  Day 8 
LPS injected* 
%  %  % 
Nontreated  11  _+ 3§  24  +_ 2  36  _+  6 
DNase-treated  11  _+ 4  25  _+ 2  35  _+  6 
Control  Nontreated  NI~]  10  -+ 2  11  -+ 4 
DNase-treated  NT  9  -+ 2  10  -+ 3 
* 0.025 ml of serum was treated with 50 ~g of DNase in 0.05 ml VBS at 37°C for 3 h. Then, 0.05 ml 
of 0.015 M EDTA (pH 7.0) and 0.125 ml of borate buffer were added. After heating the mixture at 
56°C for 30 min, 0.1 ml was tested for the DNA-binding activity. In the control tubes, EDTA was 
added before DNase in order to prevent its enzyme action. 
* 100 ~g S. typhimurium  LPS were injected intraperitoneally into C57BL/6 mice on day 0. 
§ Mean of seven mice  _+  1 SD. 
II NT, not tested. 
anti-DNA antibodies,  the presence of DNA-anti-DNA complexes in circulating 
blood was investigated.  The level of anti-DNA antibodies was assessed in sera 
collected  12 h  to 15 days  after injection of LPS,  with or without treatment  of 
DNase.  There was no  increase  in the  serum  DNA-binding  activity  after the 
digestion of sera with DNase (Table II). 
The presence of circulating immune complexes after injection of LPS was also 
studied by measurement  of the serum  [125I]Clq-binding activity.  During day 1 
and day 3 after injection of LPS, there was no increase in the [12sI]Clq-binding 
activity (Fig. 2). From day 5 to day 30, a slight, but significant, increase in the 
[12~I]Clq-binding activity was observed. In order to characterize the Clq-binding 
material  in  sera  of mice  injected  with LPS,  sera  which  exhibited high  Clq- 
binding activity were pooled and subjected to various treatments.  One serum 
pool was subjected to reduction with 0.2 M 2-ME and alkylation with iodoaceta- 
mide. This treatment abolished most of the Clq-binding activity (% binding: 2- IZUI,  LAMBERT,  FOURNII~., TURLER,  AND  MIESCHER 
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FIG.  2.  Circulating immune complexes and C3 levels in mice injected with LPS. 100 ~g of 
S. typhimurium LPS was injected intraperitoneally  on day 0 into C57BL/6 mice. The level of 
circulating immune complexes (O---O) was measured by the [l~sI]Clq-binding test. Results 
are expressed as the mean percentage of [125I]Clq precipitated (7-10 mice in each examina- 
tion). Blood C3 level (©--©) was measured by quantitative radial immunodiffusion. Results 
are expressed as the mean percentage of normal pooled values. Vertical bars represent the 
limits of 1 SD. The upper shadowed area in the figure indicates the mean -  1 SD range for 
C3 level in the control mice. The lower shadowed area indicates the mean +_  1 SD range for 
[125I]Clq-binding activity in the control mice. 
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TABLE III 
Effect of DNase Treatment on Serum Cl q-Binding Activity 
Sera  Treatment  [125I]Clq ppt,* day 8 
LPS-injected$  Nontreated  21.9§ 
DNase-treated.  23.7 
Control  Nontreated  5.1 
* 0.05 ml of pooled serum was treated with 50 tLg of DNase in 0.05 ml VBS at 37°C for 
3 h  followed by the incubation with 0.2 ml of 0.2 M EDTA (pH 7.0) at 37°C for 30 
rain. Then, 0.05 ml of [125I]Clq and 1.75 ml of 3% PEG in borate buffer were added 
and incubated at 4°C for 1 h. In the control tubes, EDTA was added before DNase in 
order to prevent its enzyme actian 
100 tLg S. typhimurium LPS were injected intraperitoneally into C57BL/6 mice on 
day 0. 
§ Mean of duplicate. 
ME treated, 8.9%; nontreated, 26.7%). The same treatment led to a decrease in 
the Clq-binding activity of aggregated human IgG  (0.5 mg/ml) from 52.9 to 
9.0%. It was found that DNA was not part of the Clq-binding material since the 
Clq-binding activity of the same serum pool did not change after treatment with 
DNase (Table III). One should note that blood C3 levels dropped significantly 
after the appearance of the Clq-binding material in circulating blood (Fig. 2). 
Immune Complexes in Renal Glomeruli after Injection of  LPS.  The glomer- 
uli of C57BL/6 mice injected intraperitoneally with 100 ~g S. typhimurium LPS 
showed minimal histologic alterations. 2 wk after injection of LPS, abnormal 
segmentation of the glomerular tufts,  focal increase in mesangial substance 
and, in some glomeruli, mesangial cell proliferations were observed. Electron 
microscopically, all  glomeruli showed  segmental or  focal intercapillary cell 
proliferations. Some glomeruli showed extensive focal thickening of GBM and 
the presence of subepithelial nodules. These nodules had the same apparent 1122  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
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FIO. 3.  Time-coupe of cumulative incidence of glomemlar IgM (&), IgG (©), and C3 (0) 
deposits  after  a  single  injection of LPS.  100  ~g  of S.  typhimurium  LPS  was  injected 
intraperitoneally on day 0 in 8- to 10-wk-old C57BL/6 mice. The total number of mice with 
the gloraerular deposits is expressed as percent of all mice (7-10 mice in each examination). 
density as the basement membrane and were often associated with fusion of the 
epithelial cell foot processes. 
Immunohistochemical  studies were carried out on mouse kidneys obtained 1- 
30 days after injection with 100 p~g S. typhimurium  LPS (Fig. 3). 3 days after 
injection with LPS, a  small amount of IgM was found in the mesangial areas 
and along the glomerular capillary walls in three out of eight mice. No glomeru- 
lar localization of  IgG and C3 was observed at this time. From day 5 to day 15, all 
mice examined showed fine granular IgM deposits along the glomerular capil- 
lary walls as  well  as  in mesangial areas  (Fig.  4a).  Less intense,  granular 
deposits of IgG and C3 were found in similar locations to the IgM deposits (Fig. 
4 b). Only 2 out of 20 control mice showed deposits of immunoglobulins (IgG and 
IgM) and C3 in glomeruli. In similar experiments, it was found that a  single 
injection of S. typhimurium  LPS induced glomerular deposits as well as anti- 
DNA antibodies in other strains tested: BALB/c, DBA/2, and OF1 outbred mice. 
Involvement of Anti-DNA Antibodies  in Glomerular Deposits.  The induc- 
tion of glomerular deposits of immunoglobulins by a single injection of LPS was 
studied in relation to the doses of LPS injected. Five groups of C57BL/6 mice 
were injected with different doses of S. typhimurium  LPS ranging from 0.1 to 
100/~g/mouse. Mice injected with more than 10 ftg of LPS developed significant 
amounts of anti-DNA antibodies as well as granular immunoglobulin deposits 
in the glomeruli (Table IV).  Less than 1 fig of LPS did not induce anti-DNA 
antibodies nor renal deposits, although anti-LPS antibodies were detected. LPS 
of other origins, either 100 fig of LPS from S. enteriditis, E. coli 0127:B8, or E. 
coli  011hB4,  were injected intraperitoneally into C57BL/6 mice. All the LPS 
tested were able to induce similar glomerular deposits as well as an anti-DNA 
response.  A  single injection of 50  ~g of lipid A,  the  active part of the LPS 
molecule, had similar effects. LPS from S.  typhimurium  was mildly treated 
with alkali to reduce the immunogenicity of LPS (20). 100/~g of alkali-treated 
LPS was injected into seven C57BL/6 mice. Mice injected with alkali-treated 
LPS developed low,  but still significant, titers of anti-DNA antibodies (Table 
IV), but they did not show a significant increase in serum LPS-binding activity. 
Six out of seven mice showed granular immunoglobulin deposits in glomeruli of 
kidneys taken on day 15. 
The presence of granular deposits of immunoglobulins and C3 in renal glo- IZUI,  LAMBERT, FOURNIE,  TURLER,  AND  MIESCHER  1123 
FIG. 4.  Glomerular IgM (a) and C3 (b) deposits in the mesangial areas and along the 
glomerular capillary  walls  15 days after a single intraperitoneal injection  of 100 /~g  S. 
typhimurium LPS. Original magnification, 200. 
meruli of mice suggested immune complex deposition.  Kidney sections were 
treated with an  acid buffer (pH  3.0) or  2.5  M  KSCN  (pH  6.0) followed by 
immunofluorescence  analysis. These treatments caused a marked reduction in 
fluorescence of glomerular deposits.  In contrast,  immunoglobulins were not 1124  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
TABLE  IV 
Anti-DNA, Anti-LPS Antibodies, and Glomerular Deposits after Injection of Various 
Doses of LPS or Alkali-Treated LPS 
Glomerular de- 
Group  Dose  [~25I]SSDNA ppt*  [5~Cr]LPS ppt~  posits§ 
LPSl 
Ptg  %  % 
0.1  14  ±  3  15  ±  5  0/7¶ 
1  14  ±  3  20  ±  3  1/7 
10  21±  4  31±  6  7/7 
50  22  ±  5  44  ±  10  7/7 
100  24  ±  2  28  ±  8  7/7 
Alkali-LPS**  100  20  ±  3  6  ±  1  6/7 
Control  13  ±  3  7  ±  1  1/14 
* Serum [~25I]SSDNA-binding  activity  (mean ± 1 SD) examined on day 3. 
* Serum [5~Cr]LPS-binding activity  (mean ± 1 SD) examined on day 15. 
§ Glomerular immunoglobulin deposits  examined on day 15. 
II Various amounts ofS. typhimuriurn  LPS were injected  intraperitoneally  into  C57BL/6 mice on 
day 0. 
¶ Number of  positive/number  tested. 
** Alkali-treated LPS was prepared by incubating S. typhimurium LPS in distilled  water with 
half  volume of  0.25  N  NaOH  for 1 h at  37°C. 
eluted from glomeruli of sections treated with PBS  (pH  7.2) under similar 
conditions. 
To characterize more directly the possible involvement of DNA-anti-DNA 
complexes in the immune complex deposits, the immunoglobulins were eluted 
from kidneys and the nature of immunoglobulins in glomerular deposits were 
examined. For elution, kidneys from 30  mice were collected 15  days after a 
single injection of 100  ~g S.  typhimurium  LPS.  The eluates were shown by 
immunoelectrophoretic analysis to  contain mouse immunoglobulins but  not 
other mouse serum proteins. Considerable amounts of IgM (5.6 ~g/of kidneys) 
and IgG (28 ~g/g of kidneys) were eluted from kidneys with DNase treatment. 
Further treatment with KSCN resulted in the elution of significant amounts of 
IgM  (2.4 ~g/g of kidneys) and IgG (12  ~g/g of kidneys) from kidneys. Both 
eluates were pooled and tested for the antibody activity against DNA and LPS. 
Results were compared with those obtained from a  serum pool  of the same 
animals on day 15 after injection of LPS. The eluates exhibited a high binding 
activity to  [125I]SSDNA but  not to  [51Cr]LPS, while the  serum pool  showed 
higher LPS-binding activity than DNA-binding activity (Table V). A quantita- 
tive study, by serial dilution of the eluates, showed that at the same concentra- 
tion of immunoglobulins, the DNA-binding activity in the eluates could be as 
much as 50 times higher than that given by the serum. The presence of anti- 
DNA  antibodies  in  the  kidneys was  also  determined by  fixing the  eluted 
immunoglobulins to insoluble Sepharose 4B coated with DNA. Approximately 
40%  of the  immunoglobulins eluted were  capable  of binding  to  the  DNA- 
Sepharose (Table V).  Absorption of the eluates with DNA before incubation 
with [125I]SSDNA abolished most of the DNA-binding activity. The reactivity of 
the renal eluates to the DNA released into circulating blood after injection of IZUI,  LAMBERT,  FOURNI~,  TURLER,  AND  MIESCHER 
TABLE V 
Specificity of  lmmunoglobulins Eluted from Kidneys 
1125 
Ig concentration  [125i] - 
Immunoglob-  Treatment  (/~g/ml)*  SSDNA  [sxCr]LPS 
ulins  ppt~ 
IgM  IgG  ppt$ 
%  % 
Eluates§  Unabsorbed  83  400  48  8 
Absorbec~l  54  285  15  6 
IgM Control¶  Unabsorbed  94  NT**  11  6 
Absorbed  93  NT  12  5 
IgG Control¶  Unabsorbed  NT  385  l0  5 
Absorbed  NT  350  12  5 
Serum** 
LPS injected  Unabsorbed  1,800  14,000  22  51 
Control  Unabsorbed  900  9,200  11  3 
* The concentration of immunoglobulins was estimated by a radial immunodiffusion in agar. 
$10-/~l eluates or control immunoglobulins were incubated with 10 ng of [12~I]SSDNA or 100 ng of 
[~ICr]LPS in the presence of 10 ~l of beat-inactivated NMS containing 3 mM EDTA. For serum, 
10 ~l of heat-inactivated sera were incubated with either [~25I]SSDNA or [5~Cr]LPS. 
§ Immunoglobulins  eluted from mouse kidneys  obtained  15  days  after  injection of 100  ~g S. 
typhimurium  LPS. 
H  Absorbed with Sepharose 4B coated with DNA. 
¶ Purified mouse myeloma proteins. 
** NT, not tested. 
*$ Collected on day 15 from the same mice for elution experiments. 
LPS  was  also  investigated.  The  eluates  exhibited  a  significant binding  to 
[x25I]DNA purified from circulating blood of LPS-injected mice (% binding _+  1 
SD: eluates diluted 1/lO in 10% NMS, 19.4 _+ 0.1%; NMS, 8.5 -+ 1.3%). From the 
results obtained in the elution experiments, we concluded that at least part of 
the immune complex deposits in the glomeruli were DNA-anti-DNA complexes. 
Discussion 
DNA has been demonstrated in circulating blood in various clinical conditions 
(1, 6, 7), but the nature and the origin of this DNA has not been systemically 
defined. In mice injected with LPS, it has been suggested that DNA might be 
released from endogenous cells or from infectious agents (18). The present data 
demonstrate that the circulating DNA released after injection of LPS has a 
similar density to mammalian cellular DNA. In the preliminary hybridization 
experiments, it was found that this released DNA contained mainly mouse DNA 
sequences. One should also note that no detectable DNA was present in the 
preparations of LPS which has been used.  It is likely that  LPS caused the 
release of DNA from host cells into circulating blood. Although cellular origin of 
DNA is difficult to define, cells which are damaged, directly or indirectly, by 
LPS may be responsible for the release of DNA (34). One should note that this 
DNA was of relatively small size (4-6S).  DNA may have been excreted as a 
small fragment of DNA from intact cells (35). Alternatively, DNA may have 1126  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
been partially digested by serum or cellular DNase. Immunochemical analysis 
indicates that the specificity of the purified DNA corresponds to a mixture of 
SSDNA and DSDNA or DSDNA with some single-stranded regions. A broader 
peak of released DNA in CsC1 density gradient may be due to the low molecular 
weight of this released DNA and may also represent a mixture of DSDNA and 
SSDNA.  Since SSDNA is iodinated more efficiently than DSDNA (21), a mix- 
ture  of DSDNA  and  SSDNA  which had  been  iodinated together would be 
overrepresented in relation to labeled molecules for SSDNA. 
It was confirmed that anti-DNA antibodies are induced within a  few days 
after a single injection of LPS. These antibodies react largely with SSDNA but 
can also react with the DNA which was purified from the plasma of  mice injected 
with LPS.  The possible mechanisms involved in the formation of these anti- 
DNA antibodies have been previously discussed (18). We consider that this 
results either from a polyclonal stimulation of B lymphocytes  or from a concomi- 
tant stimulation of B lymphocytes  by LPS and by DNA released from host cells. 
The two phenomena observed, (a) release of DNA and (b) formation of anti- 
DNA antibodies, suggest the possible occurrence of DNA-anti-DNA complexes 
in serum or in tissues. In serum, DNA-anti-DNA complexes were not detected 
using a  direct antigen-specific method nor an indirect Clq-binding test com- 
bined with DNase treatment of the sample. The results may be explained by the 
fact that the half life of the DNA released into circulating blood appears to be 
very short (18, 36), while anti-DNA antibodies are not detected before 3 days 
after the injection of LPS. There is no apparent coexistence of DNA and anti- 
DNA antibodies in plasma. However, unidentified immune complex-like mate- 
rial was demonstrated in serum, using the Clq-binding test, 5-8 days after the 
injection of LPS in mice. 
In tissues, the deposition of immune complex-like material after injection of 
LPS seems to occur, particularly in renal glomeruli. Indeed, the presence of 
immunoglobulin deposits, in association with C3, in a granular pattern within 
glomerular capillary walls and  mesangium is  suggestive of a  deposition of 
immune complexes.  Such deposits may also  correspond to  the  subepithelial 
nodules observed in electronmicroscope studies.  There is good  evidence that 
DNA-anti-DNA antibody complexes are involved in these glomerular deposits. 
(a) The granular immunoglobulin deposits which were found as early as 3 days 
after the injection of LPS were simultaneous with the appearance of anti-DNA 
antibodies in circulating blood. A direct correlation was observed between the 
level of circulating anti-DNA antibodies and the intensity of the glomerular 
deposits.  (b) Immunoglobulins with anti-DNA activity were eluted from the 
kidneys of mice injected with LPS. Quantitatively, about 40% of the immuno- 
globulins eluted were anti-DNA antibodies. The DNA-binding activity in the 
eluates was more than 50 times higher than that of the serum, at the same 
concentration of immunoglobulins. It was noteworthy  that anti-DNA antibodies 
eluted from kidneys reacted with the DNA purified from plasma of mice injected 
with LPS. The presence of other types of immune complexes in the glomerular 
deposits was also suggested by the fact that about 60% of immunoglobulins in 
the renal eluates could not be absorbed with DNA. Such unidentified complexes 
may involve endogenous antigens such as immunoglobulins, or microbial anti- 
gens such as C-type virus-associated proteins. Indeed, LPS is known to activate IZUI,  LAMBERT,  FOURNIE,  TURLER,  AND  MIESCHER  1127 
endogenous C-type virus in mouse spleen cell cultures (37) and this type of 
immune complex is found to be associated with DNA-anti-DNA complex depos- 
its in the renal lesions of NZB x  NZW FI hybrid mice (38). The present data do 
not support the hypothesis that LPS-anti-LPS complexes are involved in the 
renal deposits since the renal deposits also occurred in conditions where no 
antibodies to LPS were detectable. 
The fact that  DNA-anti-DNA complexes were not detected in  circulating 
blood,  and that the glomerular deposits preceded the occurrence of circulating 
immune complex-like material, would be in agreement  with the hypothesis that 
the deposition of DNA-anti-DNA complexes in the glomeruli would not be due to 
a direct deposition of circulating  complexes. Recently, it was demonstrated that, 
in vitro, DNA alone can bind to GBM and subsequently react with circulating 
free anti-DNA antibodies thus forming immune complexes directly on GBM 
(14). In vivo, the treatment of mice with LPS was shown to favor the binding of 
injected DNA to renal structures. Therefore, one can imagine that some of the 
DNA released into the general circulation or within renal arterioles or capillar- 
ies would first bind to GBM.  This binding would be favored by the increased 
vascular permeability or the endothelial damage induced by LPS (34, 39, 40). In 
a  second step, the anti-DNA antibodies appearing in circulating blood 3 days 
later may react with such bound DNA and form immune complexes. 
Similar mechanisms may be involved in the pathogenesis of SLE, as for the 
deposition of immune complexes in kidneys and also for the development of 
lesions in other tissues. The present observations also suggest that a release of 
bacterial products may be partly responsible for the exacerbation of SLE during 
gram-negative bacterial infections. 
Summary 
After injection of lipopolysaccharides (LPS) in mice, there is first a release of 
DNA  into  plasma  and  secondly an  induction of anti-DNA  antibodies.  The 
circulating DNA  was  purified from plasma  and  physico-immunochemically 
characterized. This DNA has a similar density to mammalian cellular DNA, is 
4-6S  in  size,  and  probably  represents  a  mixture  of single-stranded  DNA 
(SSDNA) and double-stranded DNA (DSDNA) or DSDNA with some single- 
stranded regions. This purified DNA was shown to react with anti-DNA anti- 
bodies which appeared as early as 3 days after a single injection of LPS in mice. 
In serum, DNA-anti-DNA complexes were not detected, although unidentified 
circulating immune complex-like material was demonstrated 5-8 days after the 
injection of LPS.  In  tissues,  particularly in  renal  glomeruli,  fine granular 
immune complex-type immunoglobulin deposits appeared along the glomerular 
capillary walls and in the mesangium 3 days after the injection of LPS. There is 
a direct correlation between the level of anti-DNA antibodies and the intensity 
of glomerular deposits and about 40% of immunoglobulins eluted from kidneys 
are anti-DNA antibodies, indicating that some of the immune complexes local- 
ized in kidneys are DNA-anti-DNA complexes. 
Based on these observations, the following hypothetical mechanism for the 
glomerular localization of DNA-anti-DNA complexes after the injection of LPS 
in mice is proposed.  First, DNA, which has been released in circulating blood 
after injection of LPS, might bind to renal glomeruli, probably on glomerular 1128  DNA-ANTI-DNA  COMPLEXES  INDUCED  BY  LIPOPOLYSACCHARIDE 
basement membranes (GBM) through a  high affinity of GBM for DNA; sec- 
ondly, circulating anti-DNA antibodies, which appear later, might react with 
the  glomerular-bound  DNA  and  form  immune  complexes  independently of 
circulating immune complexes. However, the possibility of direct deposition of 
immune complexes is not ruled out. 
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